| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0272-6386(99)70146-0 |
| P698 | PubMed publication ID | 10352197 |
| P50 | author | Masafumi Fukagawa | Q56997226 |
| P2093 | author name string | Suzuki H | |
| Saito A | |||
| Kurokawa K | |||
| Sakai H | |||
| Hida M | |||
| Kakuta T | |||
| Fujisaki T | |||
| P2860 | cites work | Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia | Q34215550 |
| Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases | Q34421469 | ||
| Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients | Q34622644 | ||
| Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. | Q40305016 | ||
| The pathogenesis of parathyroid gland hyperplasia in chronic renal failure | Q40415829 | ||
| Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: a theoretical approach. | Q40957786 | ||
| Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. | Q41050221 | ||
| Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism | Q41408951 | ||
| Imaging of the parathyroid in chronic renal failure: diagnostic and therapeutic aspects. | Q41571137 | ||
| Correction of severe secondary hyperparathyroidism in two dialysis patients: surgical removal versus percutaneous ethanol injection | Q44009536 | ||
| Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism | Q50112353 | ||
| Surgical treatment of renal hyperparathyroidism. | Q51547314 | ||
| Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. | Q54194022 | ||
| Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function | Q57226014 | ||
| Successful ultrasonically guided percutaneous ethanol injection for secondary hyperparathyroidism | Q67582904 | ||
| Percutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidism | Q69894249 | ||
| Estimation of Biologically Active Intact Parathyroid Hormone in Normal and Hyperparathyroid Sera by Sequential N-terminal Immunoextraction and Midregion Radioimmunoassay | Q70164649 | ||
| The spectrum of bone disease in end-stage renal failure--an evolving disorder | Q70580279 | ||
| Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism | Q71184058 | ||
| Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis | Q71775218 | ||
| Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH | Q71964275 | ||
| Chemical parathyroidectomy for recurrence of secondary hyperparathyroidism | Q72173018 | ||
| Tertiary hyperparathyroidism treated by ultrasonically guided percutaneous fine-needle ethanol injection | Q72432016 | ||
| Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients | Q72432019 | ||
| Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy | Q72559006 | ||
| Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease | Q72664908 | ||
| Acute hypoparathyroidism after percutaneous fine-needle ethanol injection (PFNEI) in a patient on haemodialysis | Q72828953 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1091-1099 | |
| P577 | publication date | 1999-06-01 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients | |
| P478 | volume | 33 |
| Q36523938 | Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease. |
| Q44603647 | Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism |
| Q40318011 | Current status of parathyroidectomy for secondary hyperparathyroidism in Japan |
| Q35573596 | Effects of percutaneous ethanol injection therapy on subsequent surgical parathyroidectomy |
| Q40318401 | Indication and efficacy of PEIT in the management of secondary hyperparathyroidism |
| Q35573606 | Long-term prognosis of parathyroid function in chronic dialysis patients after PEIT-a single-centre trial. |
| Q38487229 | Medical management after parathyroid intervention |
| Q40318080 | New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients. |
| Q35573604 | Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid Intervention |
| Q43018708 | Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. |
| Q44252563 | Prognosis of parathyroid function after minimally invasive radioguided parathyroidectomy (MIRP) and percutaneous ethanol injection therapy (PEIT) for primary hyperparathyroidism |
| Q44647160 | Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism |
| Q35568749 | Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment |
| Q73114870 | Selective percutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients--the Japanese strategy. Japanese Working Group on PEIT of Parathyroid, Tokyo, Japan |
| Q34072133 | Sonography of the thyroid and parathyroid glands |
| Q37402493 | Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis |
| Q36638034 | The kidney and bone metabolism: Nephrologists' point of view. |
| Q79983727 | [Surgical treatment of refractory hyperparathyroidism and usefulness of the intraoperative PTH] |
Search more.